Genomic progression in mouse models for liver tumors.
Genomic progression in mouse models for liver tumors.
复制标题
肝肿瘤小鼠模型的基因组进展。
DOI:
10.1101/sqb.2005.70.058
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Bishop,JM
中科院分区:
文献类型:
--
作者:
Tward,AD;Jones,KD;Yant,S;Kay,MA;Wang,R;Bishop,JM
The principal cause of human liver cancer is infection with hepatitis viruses B and C, but tumor progression is fueled by ensuingperturbations that confer gain of function on proto-oncogenes or loss of function on tumor suppressor genes. Frequentamong these perturbations is overexpression of the proto-oncogene MET. We have modeled the pathogenesis of liver tumorsby expressing conditional transgenes of MET in the hepatocytes of inbred mice. The response to the MET transgene variedwith both the magnitude and timing of its expression but included hyperplasia of hepatic progenitor cells, as well as benignand malignant tumors that display both phenotypic and genotypic resemblances to human counterparts. The results revealMET to be a crucial switch in the development of the liver; dramatize how different cellular compartments within a developmentallineage can give rise to distinctive tumor stem cells; delineate rules of tumor progression; provide evidence that theexperimental tumors in mice are authentic models for human tumors; and support a role for MET in the genesis of humanliver tumors. The models should be useful in elucidating the mechanisms of tumorigenesis and in the preclinical testing ofnew therapeutics.